Global Breast Implants Market Offered in New Research Forecasted through 2028
                     Breast Implants Market 
Breast Implants Market Forecast to 2027 - 
COVID-19 Impact and Global Analysis by 
Product (Silicone and Saline); Application 
(Reconstructive Surgery and Cosmetic 
Surgery), Surface Type (Smooth and 
Textured), and Geography
Breast Implants Market 
Current and future Market Scenario
 The breast implants market was valued at US$1,535.96 million in 2019 and is projected to reach US$2,278.40 million by 
2027; it is expected to grow at a CAGR of 5.2% during 2019–2027.
 North Americaled the market and itis anticipated to be the highest revenue contributor duringthe forecast period. Rising 
prevalence of the breast implants surgeryis expected to fuelthe growth of the breast implants market in this region.
 Market Insights
 Increasing Prevalence of Breast Cancer
 Rising prevalence of breast cancer among women across the world has led to an increase in the demand for breast 
implants. The disease is common in developed and developing countries across the globe. As per the Breastcancer.org, in 
2018, in the US, nearly 266,120 new cases of invasive breast cancer are expected to be diagnosed in women along with 
63,960 new cases of non-invasive breast cancer. Deaths rates due to breast cancer among the women in the US are high 
than other types of cancer. In 2018, nearly 40,920 women in the US died due to breast cancer. The number of new cases 
for breast cancer in men isless compared to women. Beastcancer.org stated that in 2018, about 2,550 new cases of 
invasive breast cancer were  diagnosed in men.
Key Findings
 New Product Launches & FDA Approvals
 The market for breast implants is also driven by new product launches and FDA approvals. Most of the market players 
are engaged in manufacturing various types of breast implants offering maximum advantages with high quality. For 
instance, in January, 2018, Sientra, Inc. received the US Food and Drug Administration (FDA) approval of the site-
change PMA supplement for its contract manufacturer “Vesta” to manufacture Sientra’s silicone gel breast implants. 
Moreover, in January, 2017, Allergan plc received approval from the FDA to market NATRELLE INSPIRA SoftTouch breast 
implants in the US. Additionally, in October 2017, Mentor Worldwide LLC announced the availability of MemoryGel 
Xtra breast implants in the US.
 ProductInsights
 The global breast implants market by silicon was led by productsegment. The other segment, saline considered in the 
breast implants market expected to grow at the significant rate in the forecast period.
Breast Implants Market 
 
Market Segments
By Product (Plasma Derived  
Coagulation Factor Concentrates, 
Treatment Type (On-demand, 
Recombinant Coagulation Factor Disease 
Prophylaxis); Therapy 
Concentrates, Desmopressin, (Hemophilia A, Hemophilia B, 
(Replacement Therapy, ITI Therapy, 
Antifibrinolytic Agents) Hemophilia C)
Gene Therapy, Antibody Therapy)
Breast Implants Market 
Dominating Segments
 
 Application Insights
 
 The global breast implants market by cosmetic surgerywas led by application segment. The other, 
reconstructive surgery segment, considered in the breast implants market expected to grow at the significant 
rate in the coming years.
 Surface Type Insights
 The global breast implants market by smooth segment was led by application segment. The other, textured 
segment, considered in the breast implants market anticipated to grow at the significant rate in the coming 
years.
DoPmrodinucat tInisnigh tSs egments
 Strategic Insights
 Acquisitionand agreement were observed as the most adopted strategy in global breast implants industry. Few of 
the recent acquisition and agreement are listed below; 
 2016: Sientra acquired Specialty Surgical Products, Inc. (SSP), with this acquisition the company will enhance its 
product portfolio of Dermaspan andAlloX2 lines of breast tissue expanders products.
 2016: Sientra signed service agreement with Vesta, a Lubrizol LifeSciences company. Under this agreement Vesta is 
inaugurating manufacturing unit for Sientra and serve a long-term supply agreement for its PMA-approved breast 
implants.
 2017: Allergan acquired LifeCell Corporation which is a regenerative medicine company. The acquisition will 
combine regenerative medicines business, LifeCell's novel with the Allergan’s products such as breast implants, 
tissue expanders, and medical aesthetics.
Dominating Segments
 2017: Allergan acquired Keller Medical, Inc. is a medical device company which develops Keller Funnel. The 
Keller will combine Keller Funnel with Allergan’s breast implants business.
Download PDF Brochure https://www.theinsightpartners.com/sample/TIPHE100000849/ 
GLOBAL BREAST IMPLANTS – MARKET SEGMENTATION
By Product
Silicon
Saline
By Application
Cosmetic Surgery
Reconstructive Surgery
Dominating Segments And Geography
By Surface Type
Smooth
Textured
 By Geography
North America
US
Canada
Mexico
Europe
France
Germany
UK
Italy
Spain
Rest of Europe
Breast Implants Market  
Geography
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Rest of APAC
Middle East and Africa (MEA)
Saudi Arabia
South Africa
UAE
Rest of MEA
South and Central America (SCAM)
Brazil
Argentina
Rest of SCAM
Breast Implants Market  
Leading Players
Company Profiles in Dry Eye Products Market are:
Allergan plc.
Mentor Worldwide LLC (J&J)
GC Aesthetics
Sientra, Inc.
POLYTECH Health & Aesthetics GmbH
Ideal Implant Incorporated
Silimed
Group Sebbib SAS
Guangzhou Wanhe Plastic Materials Co., Ltd
HANSBIOMED CO. LTD
  REGIONAL FRAMEWORK
REGIONAL FRAMEWORK
  Breast Implants Market  
 
 
 Breast Implants Market 
 
        
Access Full Research Report at: 
https://www.theinsightpartners.com/reports/breast-implants-market 
 
Thank You! 
Thank You!